Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study.
Ku G, Haag GM, Park H, Lam VK, George TJ, Kim SS, Gutierrez M, Shankaran V, Stein S, Denlinger CS, Elimova E, Nagrial A, He AR, Sawyer MB, Yoon HH, Geva R, Starr J, Curigliano G, Golan T, von Moos R, Fritsch R, Lim D, Wang Q, Patel A, Aoyama T, Lei M, Greenawalt D, Di Bartolomeo M. Ku G, et al. Among authors: george tj. ESMO Open. 2025 Jan 10;10(2):104107. doi: 10.1016/j.esmoop.2024.104107. Online ahead of print. ESMO Open. 2025. PMID: 39798422
Blueprint for Building and Sustaining a Cardiogenic Shock Program: Qualitative Survey of 12 US Programs.
Yau RM, Mitchell R, Afzal A, George TJ, Siddiqullah S, Bharadwaj AS, Truesdell AG, Rosner C, Basir MB, Fisher R, Dupont A, Alviar CL, Chweich H, Kapur NK, Patel RAG, Silvestry S, Patel SM, Abraham J. Yau RM, et al. Among authors: george tj. J Soc Cardiovasc Angiogr Interv. 2024 Oct 17;3(11):102288. doi: 10.1016/j.jscai.2024.102288. eCollection 2024 Nov. J Soc Cardiovasc Angiogr Interv. 2024. PMID: 39649821 Free PMC article.
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. George TJ, et al. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. JCO Precis Oncol. 2024. PMID: 39626160 Free PMC article. Clinical Trial.
Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers.
Hanvey GA, Kacel EL, Bacharz KC, Wilborn AP, Mesa S, McCracken H, Estores IM, Markham MJ, Kaye FJ, Jones D Jr, George TJ, Pereira DB. Hanvey GA, et al. Among authors: george tj. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241283113. doi: 10.1177/15347354241283113. Integr Cancer Ther. 2024. PMID: 39423043 Free PMC article.
Hospital and surgeon surgical valvar volume and survival after multivalve cardiac surgery in Medicare beneficiaries.
McCullough KA, Eisenga JB, Banwait JK, Gasparini A, Harrington KB, George TJ, Hutcheson KA, Smith RL 2nd, Brinkman WT, DiMaio JM, Schaffer JM. McCullough KA, et al. Among authors: george tj. J Thorac Cardiovasc Surg. 2024 Sep 5:S0022-5223(24)00778-5. doi: 10.1016/j.jtcvs.2024.08.044. Online ahead of print. J Thorac Cardiovasc Surg. 2024. PMID: 39243959
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis.
Chibaudel B, Raeisi M, Cohen R, Yothers G, Goldberg RM, Bachet JB, Wolmark N, Yoshino T, Schmoll HJ, Kerr R, Lonardi S, George TJ, Shacham-Shmueli E, Shi Q, André T, de Gramont A. Chibaudel B, et al. Among authors: george tj. J Clin Oncol. 2024 Dec 10;42(35):4187-4195. doi: 10.1200/JCO.24.00394. Epub 2024 Sep 4. J Clin Oncol. 2024. PMID: 39231393
314 results